Hal Applebaum
Cardiovascular Disease · Tampa, FLNPI 1639186042
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,144 of the $6,862 with a category attached, or 89.5%. It is spread thinly across 29 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,479 and has fallen 90.7% since, to $230 in 2023.
Across 325 payments — averaging $21.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Amgen$917
- Amarin Pharma, Inc.$803
- Boehringer Ingelheim$784
- Johnson & Johnson$626
- Novartis$395
- plus $2K from 23 others
What the payments were for
- Travel & lodging$6529%
- Food & beverage$6,14490%
- Education$661%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 11 | $1,052 |
| Amgen | 54 | $917 |
| Amarin Pharma, Inc. | 44 | $803 |
| Boehringer Ingelheim | 32 | $784 |
| Johnson & Johnson | 38 | $626 |
| Novartis | 22 | $395 |
| Pfizer | 20 | $310 |
| Regeneron Healthcare Solutions, Inc. | 13 | $309 |
| Abbott | 6 | $214 |
| Sanofi-aventis U.S. LLC | 16 | $210 |
| E.r. Squibb & Sons, L.L.C. | 11 | $198 |
| Bardy Diagnostics, Inc. | 7 | $173 |
| AstraZeneca | 9 | $149 |
| Esperion Therapeutics, Inc. | 7 | $118 |
| Medtronic(2 entities) | 5 | $98 |
| Edwards Lifesciences | 5 | $89 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $62 |
| Lundbeck LLC | 3 | $58 |
| Merck | 4 | $56 |
| Preventice Services, LLC | 2 | $41 |
| Astellas Pharma US Inc | 2 | $38 |
| Abiomed | 1 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Chiesi USA, Inc. | 2 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Novo Nordisk | 1 | $19 |
| Philips North America LLC | 1 | $17 |
| Portola Pharmaceuticals, LLC | 1 | $12 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$962
- Vascepa$125
- JARDIANCE$119
- Quadra Assura CRT Defibrillator$118
- Repatha$106
How this compares
$6,862 in reported general payments places this provider in the 70th percentile of 1,740 cardiovascular disease providers in Florida.
Other cardiovascular disease in Tampa
- Hiram BezerraTampa$698K
- James SmithTampa$324K
- David WilsonTampa$258K
- Robby WuTampa$190K
- Jason FelibertiTampa$138K
- Samip VasaiwalaTampa$126K
- Kevin MakatiLutz$1.6M
- William OneillNaples$637K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.